España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
J.P. Morgan & Co.
J.P. Morgan Reiterates Underweight Rating, $18 PT on Quality Systems
J.P. Morgan Reiterates Neutral Rating, $25 PT on Coeur d'Alene Mines Corporation
J.P. Morgan Reiterates Overweight Rating on Comerica
J.P. Morgan Reiterates Neutral Rating, $25 PT on Coeur d'Alene Mines Corporation
J.P. Morgan Reiterates Overweight Rating on Comerica
UPDATE: J.P. Morgan Reiterates Neutral Rating, Raises PT on Washington Federal
J.P. Morgan Reiterates Underweight Rating on Xerox Corporation
UPDATE: J.P. Morgan Reiterates Neutral Rating, Raises PT on Washington Federal
J.P. Morgan Reiterates Underweight Rating on Xerox Corporation
UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Ford Motor Company
UPDATE: J.P. Morgan Reiterates Underweight Rating, Lowers PT on Cypress Semiconductor Corporation
Read More...
J.P. Morgan & Co. Recent News
UPDATE: J.P. Morgan Reiterates Overweight Rating, Lowers PT on Apollo Group
UPDATE: J.P. Morgan Reiterates Neutral Rating, Raises PT on Rovi Corporation
UPDATE: J.P. Morgan Upgrades Tower International to Neutral, Raises PT
J.P. Morgan Reiterates Overweight Rating, $88 PT on Genesee & Wyoming
J.P. Morgan Reiterates Overweight Rating, $60 PT on BioMarin Pharmaceutical
UPDATE: J.P. Morgan Reiterates Neutral Rating, Lowers PT on Zipcar
UPDATE: J.P. Morgan Reiterates Overweight Rating, Lowers PT on Target Corporation
UPDATE: J.P. Morgan Initiates Coverage on AbbVie with Neutral Rating, $38 PT
UPDATE: J.P. Morgan Downgrades NTELOS Holdings Corp. to Neutral, Lowers PT
UPDATE: J.P. Morgan Initiates Coverage on Dynavax Technologies Corporation with Neutral Rating
J.P. Morgan Reiterates Overweight Rating, $178 PT on Simon Property Group
J.P. Morgan Reiterates Overweight Rating on Watson Pharmaceuticals
J.P. Morgan Reiterates Neutral Rating, $16 PT on Duke Realty Corp.
J.P. Morgan Reiterates Overweight Rating on Pfizer
J.P. Morgan Reiterates Neutral Rating on Bristol Myers Squibb Co.
J.P. Morgan Reiterates Neutral Rating, $8 PT on Cousins Properties
J.P. Morgan Reiterates Neutral Rating, $24 PT on Acadia Realty Trust
J.P. Morgan Reiterates Overweight Rating on Synchronoss Technologies
UPDATE: J.P. Morgan Reiterates Overweight Rating, Lowers PT on Amarin Corporation
J.P. Morgan Reiterates Neutral Rating, $75 PT on Camden Property Trust
UPDATE: J.P. Morgan Reiterates Neutral Rating, Lowers PT on Impax Laboratories
J.P. Morgan Reiterates Neutral Rating on Stillwater Mining Company
J.P. Morgan Reiterates Neutral Rating, $74 PT on Ashland